Inventor · disambiguated record
Tse-I Lin
Also filed as: LIN TSE-I
12 granted patents·5 pending applications·91 citations·filing 2003–2019
89Inventor score
Files withTIBOTEC PHARM LTD4JANSSEN SCIENCES IRELAND UC3BAYER SCHERING PHARMA AG2BETZ ULRICH1Janssen Sciencies Ireland UC1
Top patents by PatentIndex Score
17 records- 0196US8030318B2Fused bicyclic inhibitors of HCVTIBOTEC PHARM LTD·Filed 2006·Granted Oct 4, 2011·31 cites·3 claims
- 0293US8022077B2Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereofTIBOTEC PHARM LTD·Filed 2006·Granted Sep 20, 2011·31 cites·22 claims
- 0383US7977342B2HCV inhibiting bi-cyclic pyrimidinesTIBOTEC VIRCO VIROLOGY BVBA·Filed 2007·Granted Jul 12, 2011·9 cites·9 claims
- 0480US9290502B2Pteridines useful as HCV inhibitors and methods for the preparation thereofTIBOTEC PHARM LTD·Filed 2013·Granted Mar 22, 2016·3 cites·12 claims
- 0577US9427440B2Macrocyclic indole derivatives useful as hepatitis C virus inhibitorsJANSSEN SCIENCES IRELAND UC·Filed 2013·Granted Aug 30, 2016·3 cites·13 claims
- 0677US8921355B2Macrocyclic indole derivatives useful as hepatitis C virus inhibitorsVENDEVILLE SANDRINE MARIE HELENE·Filed 2009·Granted Dec 30, 2014·5 cites·18 claims
- 0771US7960387B22-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegalovirusesBAYER SCHERING PHARMA AG·Filed 2004·Granted Jun 14, 2011·5 cites·4 claims
- 0869US7709491B2Substituted quinazolines as antiviral agents, especially against cytomegalovirusesBAYER SCHERING PHARMA AG·Filed 2003·Granted May 4, 2010·4 cites·15 claims
- 0960US9708328B2Pteridines useful as HCV inhibitors and methods for the preparation thereofJANSSEN SCIENCES IRELAND UC·Filed 2016·Granted Jul 18, 2017·0 cites·7 claims
- 1059US2017275288A1Pteridines useful as hcv inhibitors and methods for the preparation thereofJANSSEN SCIENCES IRELAND UC·Filed 2017·Application pending·0 cites
- 1159US2009156595A1Pteridines useful as HCV inhibitors and methods for the preparation thereofTIBOTEC PHARM LTD·Filed 2006·Application pending·0 cites
- 1257US9987277B2Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis CRABOISSON PIERRE JEAN MARIE BERNARD·Filed 2007·Granted Jun 5, 2018·0 cites·27 claims
- 1355US2011171174A1Synergistic Combinations of a Macrocyclic Inhibitor of HCV and a NucleosideORTHO MCNEIL JANSSEN PHARM·Filed 2009·Application pending·0 cites
- 1451US11891601B2Method to enhance the transcription regulation of SUPT4H on genes containing repetitive nucleotide sequencesUNIV NAT YANG MING·Filed 2019·Granted Feb 6, 2024·0 cites·12 claims
- 1549US9951075B2Pteridines useful as HCV inhibitors and methods for the preparation thereofJanssen Sciencies Ireland UC·Filed 2016·Granted Apr 24, 2018·0 cites·12 claims
- 1638US2007004735A1Method for inhibiting the replication of herpes virusesBETZ ULRICH·Filed 2003·Application pending·0 cites
- 1737US2013028865A1Combination of a Macrocyclic Inhibitor of HCV, A Non-Nucleoside and a NucleosideMEDIVIR AB·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tse-I Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →